Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Do these positive trends make Citigroup stock a buy now? Citigroup has undergone a significant transformation in recent years ...

This was the stock's second consecutive day of losses.

Guggenheim has reaffirmed its buy rating on The Cigna Group, setting a target price of $388, making investors grin. The Cigna ...

UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...

Guggenheim analyst Jason Cassorla maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $388.00. The company’s shares closed yesterday at $31 ...

Hims & Hers has delivered strong results and partnerships, but recent Cigna/Novo Nordisk news increases competitive risk and ...

Wall Street’s worries about a ballooning deficit that threatens America’s status as a safe haven were reflected in a $16 ...

With a market cap of $84.3 billion, The Cigna Group (CI) is a leading global health services company headquartered in Bloomfield, Connecticut, serving over 178 million customers in more than 30 ...

Bernstein analysts say the market has overreacted to President Trump’s latest executive order on drug pricing, arguing that the directive poses limited new risks to pharmacy benefit managers (PBMs) ...

Detailed price information for Onkure Therapeutics Inc (OKUR-Q) from The Globe and Mail including charting and trades.

We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where The Cigna Group ... have used the ratings by ...